Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001304166 | SCV001493438 | uncertain significance | Early myoclonic encephalopathy | 2022-03-01 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). ClinVar contains an entry for this variant (Variation ID: 1007034). This variant has not been reported in the literature in individuals affected with JMJD1C-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces proline, which is neutral and non-polar, with histidine, which is basic and polar, at codon 1381 of the JMJD1C protein (p.Pro1381His). |
Ambry Genetics | RCV004036302 | SCV003593772 | uncertain significance | not specified | 2021-10-29 | criteria provided, single submitter | clinical testing | The c.4142C>A (p.P1381H) alteration is located in exon 10 (coding exon 10) of the JMJD1C gene. This alteration results from a C to A substitution at nucleotide position 4142, causing the proline (P) at amino acid position 1381 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |